...
首页> 外文期刊>Trends in Cardiovascular Medicine >Mast Cell Chymase and Tryptase in Abdominal Aortic Aneurysm Formation
【24h】

Mast Cell Chymase and Tryptase in Abdominal Aortic Aneurysm Formation

机译:腹主动脉瘤形成中的肥大细胞酶和类胰蛋白酶

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mast cells (MCs) are implicated in the pathogenesis of atherosclerosis and abdominal aortic aneurysm (AAA). MC-specific chymase and tryptase play important roles in inducing endothelial cell expression of adhesion molecules and chemokines to promote leukocyte recruitment, degrading matrix proteins and activating protease-activated receptors to trigger smooth muscle cell apoptosis, and activating other proteases to degrade medial elastin and to enhance angiogenesis. In experimental AAA, the absence or pharmacological inhibition of chymase or tryptase reduced AAA formation and associated arterial pathologies, proving that these MC proteases participate directly in AAA formation. Increased levels of these proteases in human AAA lesions and in plasma from AAA patients suggest that these proteases are also essential to human AAA pathogenesis. Development of chymase or tryptase inhibitors or their antibodies may have therapeutic potential among affected human subjects.
机译:肥大细胞(MCs)参与动脉粥样硬化和腹主动脉瘤(AAA)的发病机理。 MC特异性的糜酶和类胰蛋白酶在诱导内皮细胞粘附分子和趋化因子的表达以促进白细胞募集,降解基质蛋白和激活蛋白酶激活的受体以触发平滑肌细胞凋亡以及激活其他蛋白酶降解内侧弹性蛋白和增强血管生成。在实验性AAA中,不存在糜蛋白酶或类胰蛋白酶或没有药理学抑制作用可减少AAA的形成和相关的动脉病变,从而证明这些MC蛋白酶直接参与AAA的形成。这些蛋白酶在人AAA病变和AAA患者血浆中的水平升高表明,这些蛋白酶对于人AAA发病机理也是必不可少的。糜蛋白酶或类胰蛋白酶抑制剂或其抗体的开发可能在受影响的人类受试者中具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号